Joseph E Aslan Selected Research

Joseph E Aslan Research Topics

Disease

12	Thrombosis (Thrombus) 02/2024 - 11/2010
5	Inflammation (Inflammations) 01/2024 - 11/2020
4	Iron Deficiencies 02/2023 - 02/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2023
2	Hemorrhage 02/2024 - 03/2016
2	Iron Overload 02/2023 - 01/2023
2	Atherosclerosis 01/2023 - 06/2022
2	Neoplasms (Cancer) 01/2012 - 09/2011
1	Thromboinflammation 01/2024
1	Stroke (Strokes) 10/2023
1	Constipation 02/2023
1	Dyspepsia (Indigestion) 02/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Fatigue 01/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Insulin Resistance 01/2023
1	Obesity 01/2023
1	Crohn Disease (Crohn's Disease) 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2022
1	Anemia 02/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Pain (Aches) 01/2022
1	Chronic Pain 01/2022
1	Sepsis (Septicemia) 05/2020
1	Pneumonia (Pneumonitis) 05/2020
1	COVID-19 05/2020
1	Body Weight (Weight, Body) 01/2020
1	Vascular System Injuries 04/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016
1	Bruton type agammaglobulinemia 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2010
1	Multiple Sclerosis 11/2010
1	Cholestasis 01/2006

Drug/Important Bio-Agent (IBA)

5	Hemostatics (Antihemorrhagics)IBA 10/2022 - 01/2012
4	IronIBA 02/2023 - 02/2022
3	Blood Coagulation Factors (Coagulation Factor)IBA 02/2024 - 05/2020
3	ibrutinibIBA 01/2023 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2020
3	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019 - 01/2012
2	CytokinesIBA 01/2022 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2016
2	CollagenIBA 01/2019 - 11/2010
1	Monoclonal AntibodiesIBA 02/2024
1	nitinolIBA 02/2024
1	Blocking AntibodiesIBA 02/2024
1	Thrombin FDA Link 01/2024
1	ProteomeIBA 10/2023
1	metal transporting protein 1 (ferroportin)IBA 02/2023
1	HepcidinsIBA 02/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	Saline SolutionIBA 01/2023
1	TicagrelorIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023
1	FlavonoidsIBA 10/2022
1	xanthohumolIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	EndocannabinoidsIBA 01/2022
1	Medical MarijuanaIBA 01/2022
1	ActomyosinIBA 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021
1	GTP Phosphohydrolases (GTPases)IBA 09/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	Adenosine Diphosphate (ADP)IBA 06/2018
1	platelet membrane glycoprotein VIIBA 03/2016
1	Phospholipases (Phospholipase)IBA 03/2016
1	bcr-abl Fusion ProteinsIBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	Chemokine ReceptorsIBA 09/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2010
1	Peptides (Polypeptides)IBA 11/2010
1	SolutionsIBA 11/2010
1	LigandsIBA 11/2010
1	fas Receptor (CD95 Antigen)IBA 01/2006

Therapy/Procedure

3	Therapeutics 02/2024 - 10/2022
2	Stents 02/2024 - 01/2012
1	Length of Stay 01/2023
1	Resuscitation 01/2023
1	Immunotherapy 01/2012